Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,036 DKK | -0.90% | +1.18% | -4.87% |
21/05 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
15/05 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.87% | 19.27B | |
+10.57% | 115B | |
+12.40% | 106B | |
-5.38% | 24.69B | |
-1.22% | 21.97B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.95% | 14.03B | |
+33.62% | 12.13B | |
-31.33% | 7.77B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab Affirms Upgraded FY22 Guidance Amid Higher Sales of Cancer Drug Darzalex